These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2888783

  • 1. Polymorphism of the T cell receptor beta-chain in Graves' disease.
    Demaine A, Welsh KI, Hawe BS, Farid NR.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):643-6. PubMed ID: 2888783
    [Abstract] [Full Text] [Related]

  • 2. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
    Ito M, Tanimoto M, Kamura H, Yoneda M, Morishima Y, Yamauchi K, Itatsu T, Takatsuki K, Saito H.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
    [Abstract] [Full Text] [Related]

  • 3. Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci.
    Demaine AG, Ratanachaiyavong S, Pope R, Ewins D, Millward BA, McGregor AM.
    Clin Exp Immunol; 1989 Jul; 77(1):21-4. PubMed ID: 2569950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.
    Mangklabruks A, Cox N, DeGroot LJ.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):236-44. PubMed ID: 1677360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Linkage of HLA-DR beta specific restriction fragment length polymorphisms with Graves' disease.
    Boehm BO, Schifferdecker E, Kuehnl P, Schöffling K.
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):251-6. PubMed ID: 2902722
    [Abstract] [Full Text] [Related]

  • 8. T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes.
    Millward BA, Welsh KI, Leslie RD, Pyke DA, Demaine AG.
    Clin Exp Immunol; 1987 Oct; 70(1):152-7. PubMed ID: 2891459
    [Abstract] [Full Text] [Related]

  • 9. T-cell receptor alpha chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' disease.
    Weetman AP, So AK, Roe C, Walport MJ, Foroni L.
    Hum Immunol; 1987 Oct; 20(2):167-73. PubMed ID: 2890606
    [Abstract] [Full Text] [Related]

  • 10. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A, Gladman DD, Chan JY, Volpé R.
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Restriction fragment length polymorphism of the T cell receptor beta-chain gene in Chinese patients with thyrotoxic hypokaleamic periodic paralysis and Graves' disease.
    Lee BW, Tan J, Yap HK, Wong SC, Poh KS, Lee KO.
    Autoimmunity; 1995 Oct; 21(4):241-4. PubMed ID: 8852514
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism in human T cell receptor alpha chain variable region genes.
    Grier AH, Mitchell MP, Robinson MA.
    Exp Clin Immunogenet; 1990 Oct; 7(1):34-42. PubMed ID: 1971756
    [Abstract] [Full Text] [Related]

  • 14. Immunogenetics of Graves' ophthalmopathy.
    Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B.
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
    [Abstract] [Full Text] [Related]

  • 15. DX alpha gene polymorphism in Graves' disease.
    Weetman AP, Roe C, So A.
    Tissue Antigens; 1988 Jan; 31(1):1-4. PubMed ID: 2893470
    [Abstract] [Full Text] [Related]

  • 16. T cell receptor beta chain gene polymorphisms in Graves' disease.
    Pickerill AP, Watson PF, Tandon N, Weetman AP.
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):499-502. PubMed ID: 8101679
    [Abstract] [Full Text] [Related]

  • 17. Further studies of genetic susceptibility to Graves' disease in a Russian population.
    Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI, Nosikov VV.
    Med Sci Monit; 2002 Mar; 8(3):CR180-4. PubMed ID: 11887032
    [Abstract] [Full Text] [Related]

  • 18. Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms.
    Demaine AG, Vaughan RW, Taube DH, Welsh KI.
    Immunogenetics; 1988 Mar; 27(1):19-23. PubMed ID: 2890576
    [Abstract] [Full Text] [Related]

  • 19. DQA2 U allele: a genetic marker for relapse of Graves' disease.
    Ratanachaiyavong S, Gunn CA, Bidwell EA, Darke C, Hall R, McGregor AM.
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):241-51. PubMed ID: 1971775
    [Abstract] [Full Text] [Related]

  • 20. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R.
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.